assessing causality among super and exceptional responders
Published 4 years ago • 1.8K plays • Length 27:49Download video MP4
Download video MP3
Similar videos
-
19:02
oncologists are sacrificing common sense in pursuit of innovation | invited lecture
-
46:44
lecture to hemeonc fellows; response rate; polo; crossover; javelin100 bladder
-
20:06
super responders in the broader precision oncology landscape
-
1:04:56
chip landmark ideas: medical reversal why 46% of what doctors think is wrong - vinay prasad, md, mph
-
31:53
lecture 2 - surrogate endpoints in oncology - reading and interpreting cancer trials
-
5:18
when are boosters justified? | a doctors take on the level of evidence
-
46:36
how to read kaplan-meier plots
-
51:27
sensible medicine superbowl edition - walensky's equipoise lie | paxlovid
-
26:07
the problem with the evidence in cancer medicine
-
34:39
the truth about randomized controlled trials in cancer medicine | ethical vs unethical studies
-
43:07
lecture 1 - lay of the land - reading and interpreting cancer trials series
-
17:25
was this cancer clinical trial unethical? | one doctor reflects on a recent controversy
-
43:05
old fashioned intelligence in cancer medicine
-
47:08
lecture 3 - fda drug approval 101- reading and interpreting cancer trials series
-
25:01
organ preservation in and head and neck cancers with dr bhavin vadodriya | medsynapse.
-
19:53
flaws in new cancer drug trial | ivosidenib & aza vs aza | agile | nejm | plenary session | timeline
-
13:47
checkmate 577 - is nivolumab adjuvant the standard of care in esophagus and gej?
-
23:54
enp2: autoimmune diabetes outcomes and anti-cancer agents
-
18:21
decisional tools to determine need for biopsy and re-biopsy in men with elevated psas